M. Wehling

1.4k total citations
12 papers, 1.1k citations indexed

About

M. Wehling is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Wehling has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Wehling's work include Muscle Physiology and Disorders (5 papers), Adipose Tissue and Metabolism (3 papers) and Platelet Disorders and Treatments (2 papers). M. Wehling is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Adipose Tissue and Metabolism (3 papers) and Platelet Disorders and Treatments (2 papers). M. Wehling collaborates with scholars based in United States, Germany and Russia. M. Wehling's co-authors include James G. Tidball, Melissa J. Spencer, Éliane Lavergne, Elizabeth M. McNally, James T. Stull, Michele Hadhazy, Kim S. Lau, Martin Feuring, Bernhard M. W. Schmidt and K Haseroth and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The FASEB Journal.

In The Last Decade

M. Wehling

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wehling United States 8 912 370 258 207 176 12 1.1k
Cathy M. Gurley United States 14 1.1k 1.2× 504 1.4× 236 0.9× 253 1.2× 158 0.9× 15 1.5k
Thea Shavlakadze Australia 16 861 0.9× 356 1.0× 200 0.8× 237 1.1× 75 0.4× 21 1.1k
Eric J. Stevenson United States 8 888 1.0× 402 1.1× 225 0.9× 244 1.2× 113 0.6× 8 1.1k
Christian Pastoret France 10 753 0.8× 196 0.5× 198 0.8× 86 0.4× 123 0.7× 13 812
Alan Koncarevic United States 8 892 1.0× 443 1.2× 230 0.9× 246 1.2× 118 0.7× 8 1.1k
Christophe Hourdé France 22 1.0k 1.1× 385 1.0× 130 0.5× 248 1.2× 144 0.8× 50 1.3k
Kathleen M. McCormick United States 11 667 0.7× 212 0.6× 134 0.5× 146 0.7× 82 0.5× 18 885
Nadia Charifi Sweden 9 856 0.9× 484 1.3× 251 1.0× 411 2.0× 55 0.3× 9 1.2k
Sajedah M. Hindi United States 19 886 1.0× 285 0.8× 126 0.5× 201 1.0× 81 0.5× 24 1.1k
I. Courdier-Fruh Switzerland 11 686 0.8× 211 0.6× 110 0.4× 118 0.6× 105 0.6× 13 829

Countries citing papers authored by M. Wehling

Since Specialization
Citations

This map shows the geographic impact of M. Wehling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wehling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wehling more than expected).

Fields of papers citing papers by M. Wehling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wehling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wehling. The network helps show where M. Wehling may publish in the future.

Co-authorship network of co-authors of M. Wehling

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wehling. A scholar is included among the top collaborators of M. Wehling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wehling. M. Wehling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Feuring, Martin, et al.. (2005). Impact of ABO blood groups on tirofiban mediated inhibition of platelet function. Platelets. 16(7). 430–434. 4 indexed citations
3.
Wehling, M., Melissa J. Spencer, & James G. Tidball. (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. The Journal of Cell Biology. 155(1). 123–132. 433 indexed citations
4.
Hadhazy, Michele, et al.. (2000). Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Letters. 474(1). 71–75. 182 indexed citations
5.
Wehling, M., et al.. (2000). Modulation of myostatin expression during modified muscle use. The FASEB Journal. 14(1). 103–110. 181 indexed citations
6.
Tidball, James G., Melissa J. Spencer, M. Wehling, & Éliane Lavergne. (1999). Nitric-oxide Synthase Is a Mechanical Signal Transducer That Modulates Talin and Vinculin Expression. Journal of Biological Chemistry. 274(46). 33155–33160. 49 indexed citations
7.
Feuring, Martin, et al.. (1999). Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).. PubMed. 37(12). 584–8. 34 indexed citations
8.
Wehling, M., James T. Stull, Timothy J. McCabe, & James G. Tidball. (1998). Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase. Neuromuscular Disorders. 8(1). 22–29. 24 indexed citations
9.
Tidball, James G., Éliane Lavergne, Kim S. Lau, et al.. (1998). Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. American Journal of Physiology-Cell Physiology. 275(1). C260–C266. 179 indexed citations
10.
Wehling, M., et al.. (1995). [Non-genomic aldosterone action. A new concept for the mechanism of action of steroids is developed].. PubMed. 36(4). 338–42. 3 indexed citations
11.
Theisen, K., et al.. (1993). Aneurysms of coronary arteries in a patient with adult polycystic kidney disease: arteriosclerosis or involvement by the primary disease?. Journal of Molecular Medicine. 71(2). 150–2. 12 indexed citations
12.
Wehling, M., et al.. (1989). Volume regulation of human lymphocytes by aldosterone in isotonic media. European Journal of Endocrinology. 120(3_Suppl). S116–S116. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026